Separately, Rakovina Therapeutics expects to receive the first synthesized drug candidates from its second AI-driven drug discovery program targeting ATR.

TORONTO, ON / ACCESS Newswire / February 6, 2025 / The CIX Startup Awards is a showcase of Canada's premier startups that are ...

Tech giant OpenAI has unveiled a pay-for-access tool called ‘deep research’, which synthesizes information from dozens or ...